How is febrile neutropenia characterized in terms of neutrophil count, fever, and C-Reactive Protein (CRP) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Febrile neutropenia is characterized by a neutrophil count below 500 cells/mm³ (or expected to fall below 0.5 x 10^9/l), accompanied by a fever of 38.5°C or higher, or two consecutive readings of 38.0°C for 2 h. This definition is based on the most recent and highest quality study available, which provides clear guidelines for the management of febrile neutropenia 1.

Key Characteristics

  • Neutrophil count: less than 0.5 x 10^9/l, or expected to fall below this level
  • Fever: oral temperature greater than 38.5°C, or two consecutive readings of greater than 38.0°C for 2 hours
  • C-Reactive Protein (CRP) levels are not explicitly defined in the guidelines, but are typically elevated in response to infection

Clinical Significance

The combination of neutropenia and fever is clinically significant because it indicates a compromised immune system, making patients vulnerable to severe infections. Even minor infections can rapidly progress to life-threatening sepsis in these patients, which is why febrile neutropenia is considered a medical emergency requiring immediate antibiotic therapy. The condition is most commonly seen in patients undergoing chemotherapy for cancer, particularly hematologic malignancies, but can occur in any situation where neutrophil production is impaired or neutrophil destruction is accelerated. More recent guidelines also provide definitions for fever and neutropenia, including a single oral temperature of ≥ 38.3°C (101°F) or a temperature ≥ 38.0°C (100.4°F) sustained over a 1-hour period, and an absolute neutrophil count < 1,000/mL (equivalent to < 1.0 x 10^9/L) for neutropenia 1. However, the most recent and highest quality study available is used to inform the definition of febrile neutropenia.

From the Research

Characterization of Febrile Neutropenia

  • Febrile neutropenia is defined by an absolute neutrophil count (ANC) less than or equal to 500 cells per microliter with a concurrent single oral body temperature of more than or equal to 38.3° C (orally) or more than 38.0° C maintained over one hour 2, 3.
  • The characterization of febrile neutropenia also involves the presence of fever, which is a critical component of the diagnosis 3, 4.
  • C-Reactive Protein (CRP) levels are not explicitly mentioned in the provided studies as a characteristic of febrile neutropenia, but the focus is on neutrophil count and fever 2, 3, 5, 6, 4.

Neutrophil Count

  • An absolute neutrophil count (ANC) of less than or equal to 500 cells per microliter is a key characteristic of febrile neutropenia 2, 3, 5, 6, 4.
  • Patients with an ANC less than 100/mm³ have been shown to have a lower treatment success rate 3.

Fever

  • Fever is defined as an oral body temperature of more than or equal to 38.3° C (orally) or more than 38.0° C maintained over one hour 2, 3.
  • The presence of fever is a critical component of the diagnosis of febrile neutropenia 3, 4.

C-Reactive Protein (CRP) Levels

  • There is no mention of CRP levels in the provided studies as a characteristic of febrile neutropenia 2, 3, 5, 6, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of the Management of Febrile Neutropenia in a Tertiary Care Center.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025

Research

A comparison of the efficacy of piperacillin-tazobactam and cefoperazone-sulbactam therapies in the empirical treatment of patients with febrile neutropenia.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2016

Research

Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.